1Perou CM,Sorlie T,Eisen MB,et al.Molecular portraits of human breast tumors[J].Nature,2000,406(6797):747.
2Sorlie T,Tibshirani R,Parker J,et al.Repeated observation of breast tumor subtypes in independent gene expression data sets[J].Proc Natl Acad Sci USA,2003,100(14):8418.
4Badve S,Turbin D,Thorat M A,et al.FOXA1 expression in breast cancer-correlation with luminal subtype A and survival[J].Clin Cancer Res,2007,13(15 Pt 1):4415.
6Bocker W,Moll R,Poremba C,et al.Common adult stem cells in the human breast give rise to glandular and myoepithelial cell lineages:a new cell biological concept[J].Lab Invest,2002,82(6):737.
7Boecker W,Buerger H.Evidence of progenitor cells of glandular and myoepithelial cell lineages in the the human adult female breast epithelium:a new progenitor (adult stem) cell concept[J].Cell Prolif,2003,36(Suppl 1):73.
8Stingl J,Eaves C J,Zandieh I,et al.Characterization of bipotent mammary epithelial progenitor cells in normal adult human breast tissue[J].Breast Cancer Res Treat,2001,67(2):93.
9Dontu G,Abdallah W M,Foley J M,et al.In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells[J].Genes Dev,2003,17(10):1253.
10Dontu G,Al Hajj M,Abdallah W M,et al.Stem cells in normal breast development and breast cancer[J].Cell Prolif,2003,36(Suppl 1):59.
4Rouzier R, Perou CM, Symmans -W-F, et al. Breast cancer molecular subtypes respond differendy to preoperative chemotherapy[J]. Clin Cancer Res, 2005, 11(16): 5678-5685.
5Colleoni M, Viale G, Zahrieh D, et al. Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment[J].Clin Cancer Res, 2004, 10(19) : 6622-6628.
6Arriola E, Moreno A, Varela M, et al. Predictive value of HER-2 and Topoisomerase Ⅱ lpha in response to primary doxorubicin in breast cancer[J] . EurJ Cancer, 2006, 42(17): 2954-2960.
7Conforti R, Boulet T, Tomasic G, et al. Breast cancer molecular subclassification and estrogen receptor expression to predict efficacy of adjuvant anthracyclines-based chemotherapy: a biomarker study from two randomized trials[J]. Ann Oncol, 2007, 18(9): 1477-1483.
8ChangJC, Wooten EC, Tsimelzon A, et al. Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer[J]. Lancet, 2003, 362(9381): 362-369.
9Kaufrnann M, von Minckwitz G, Smith R, et al. International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations[J].J Clin Oncol, 2003, 21(13): 2600-2608.
10Chollet P, Amat S, Cure H, et al. Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer[J]. BrJ Cancer,2002, 86(7): 1041-1046.
8Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours[J]. Nature,2000,406 (6797) :747.
9Ray PS,Wang J,Qu Y,et al. FOXC1 is a potential prognostic biomar- ker with functional significance in basal-like breast cancer[ J ]. Cancer Res,2010,70(10) :3870.
10Carlsson P, Mahlapuu M, Forkhead transcription factors:key players in development and metabolism[J]. Dev Biol,2002,250( 1 ) :1.
